Mycophenolic Acid (Accord Healthcare Inc.)
Welcome to the PulseAid listing for the Mycophenolic Acid drug offered from Accord Healthcare Inc.. This Antimetabolite Immunosuppressant [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Accord Healthcare Inc. |
NON-PROPRIETARY NAME: | Mycophenolic Acid |
SUBSTANCE NAME: | MYCOPHENOLATE SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antimetabolite Immunosuppressant [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, DELAYED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-09-11 |
END MARKETING DATE: | 0000-00-00 |
Mycophenolic Acid HUMAN PRESCRIPTION DRUG Details:
Item Description | Mycophenolic Acid from Accord Healthcare Inc. |
LABELER NAME: | Accord Healthcare Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 360(mg/1) |
START MARKETING DATE: | 2017-09-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 16729-189_5902a650-722c-3c98-e053-2a91aa0a9549 |
PRODUCT NDC: | 16729-189 |
APPLICATION NUMBER: | ANDA202555 |
Other MYCOPHENOLATE SODIUM Pharmaceutical Manufacturers / Labelers: